IGF2BP2 and colorectal carcinoma: In conclusion, without inhibition factors such as GATA3, LINRIS binds to the K139 ubiquitination site of IGF2BP2 and prevents it from degradation via the ALP, maintaining the MYC-mediated glycolysis and the proliferation of CRC cells (Fig. 7g).